Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 14.3;Horizontal cells: 7.9;Late spermatids: 6.0;Muller glia cells: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 17.8;NTERA-2: 6.8;REH: 7.1;SH-SY5Y: 8.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" NA NA 56000 "Vesicles, Aggresome" "HPA066973: AB_2732754" "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.3 0.2 1.0 0.3 2.8 0.3 0.3 4.8 1.4 0.3 0.5 0.3 0.3 0.2 0.4 0.6 0.3 0.2 0.3 0.3 0.5 1.3 0.3 0.3 0.4 0.5 0.3 0.3 1.1 0.7 0.2 3.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 2.6 0.4 0.6 0.3 0.3 0.5 0.6 35.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.1 0.4 0.0 0.0 4.5 0.7 0.0 0.0 0.0 0.1 0.2 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 17.8 0.1 0.6 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 0.5 0.0 0.5 0.1 1.3 6.8 0.0 1.6 7.1 1.5 0.9 0.0 0.2 0.5 8.2 0.1 0.0 1.5 0.0 0.9 0.0 0.8 0.6 1.4 0.9 2.5 5.0 3.6 0.8 0.3 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 4.8 1.4 0.5 1.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.1 14.3 0.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.3 0.6 0.1 0.5 0.0 0.2 0.2 0.4 0.1 0.0 0.2 0.1 7.9 1.2 0.6 0.0 6.0 1.4 0.0 0.0 0.0 0.7 7.2 0.0 0.0 0.4 0.2 2.2 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.6 0.1 ARHGAP35 "GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP" ENSG00000160007 "Rho GTPase activating protein 35" Q9NRY4 19 46918676-47005077 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, GTPase activation, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 167.2;Late spermatids: 476.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037311, HPA055184, HPA056470" Approved Supported "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142" "unprognostic (5.47e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (2.40e-2)" "unprognostic (2.01e-2)" "unprognostic (7.78e-3)" "unprognostic (9.82e-3)" "unprognostic (4.41e-2)" "unprognostic (2.71e-1)" "unprognostic (2.73e-2)" "unprognostic (3.25e-2)" "unprognostic (1.92e-1)" "prognostic favorable (5.55e-8)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" 4.0 3.1 11.9 1.9 9.0 0.8 5.4 6.1 11.7 4.5 4.4 3.9 3.9 3.3 5.3 4.3 2.6 8.7 10.7 9.9 6.7 7.7 4.8 2.1 8.4 6.2 4.2 17.3 4.4 2.0 4.4 3.9 4.8 5.6 9.0 3.4 5.1 4.2 4.6 2.2 3.1 13.8 7.0 2.4 4.5 2.2 1.1 1.4 0.9 1.2 1.0 3.1 1.1 20.4 23.3 15.7 13.9 14.4 12.0 2.6 11.1 16.0 11.4 13.1 12.4 7.4 11.0 7.9 45.6 17.1 12.5 14.4 14.4 15.7 7.6 6.0 14.8 16.3 9.6 13.5 8.8 12.6 12.1 14.5 12.8 13.7 15.9 10.1 7.4 9.9 4.0 13.0 12.0 8.4 13.8 8.2 14.8 8.6 9.5 10.8 3.4 9.5 40.9 15.8 15.0 20.6 19.4 8.2 10.2 18.3 10.7 12.7 10.0 8.0 10.8 13.1 4.1 7.6 9.0 22.4 9.1 24.3 0.9 1.0 0.9 2.8 0.8 2.9 0.8 2.6 3.1 1.3 1.1 1.0 1.2 0.4 1.0 1.2 1.4 0.8 1.1 41.7 35.5 3.4 12.2 13.5 31.7 53.1 25.5 8.1 19.4 24.4 23.6 3.0 6.6 11.9 167.2 19.4 41.2 0.0 17.3 0.8 13.4 22.5 9.2 80.5 12.7 65.2 30.0 28.8 14.0 476.8 21.6 7.8 20.3 15.4 22.1 28.0 16.4 17.5 24.1 18.4 23.1 19.4 17.5 42.7 22.0 14.4 1.4 13.1 23.8 11.6 C11orf74 "FLJ38678, HEPIS, NWC" ENSG00000166352 "Chromosome 11 open reading frame 74" Q86VG3 11 36594493-36659290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 66.1" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 158.0;Early spermatids: 129.9;Late spermatids: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol NA NA "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 10.7 13.1 16.0 4.2 18.8 8.6 11.5 15.5 20.8 10.5 15.4 8.7 8.3 5.5 11.8 18.5 9.5 25.3 10.1 28.1 14.3 15.4 17.1 13.1 8.1 4.1 17.2 16.5 17.8 10.2 12.5 23.1 7.9 19.6 13.3 8.3 9.0 8.6 8.2 26.5 3.8 7.5 13.1 15.5 5.7 9.7 33.1 14.5 3.5 66.1 10.8 4.0 12.5 7.3 0.3 18.6 7.5 12.5 8.5 8.2 5.8 5.3 9.1 20.1 15.6 16.5 28.3 8.0 11.2 12.7 11.6 20.5 0.3 8.6 0.0 8.8 11.4 15.1 2.3 13.6 15.3 23.0 0.0 22.0 8.8 5.1 9.9 13.8 12.0 2.2 17.8 11.9 7.7 10.9 19.0 19.0 7.9 11.8 0.0 12.8 9.0 2.1 9.9 12.8 3.1 13.9 8.6 24.5 5.2 16.1 1.8 0.5 23.9 11.5 3.0 18.4 18.7 18.4 6.5 12.1 15.9 11.4 21.0 9.5 3.3 6.1 0.0 13.9 14.4 8.2 7.5 12.5 0.7 1.1 9.7 3.7 0.0 3.3 2.8 13.7 0.3 8.2 2.0 0.7 8.5 9.1 18.6 0.4 5.8 16.0 18.8 15.5 20.8 14.3 15.4 17.2 16.5 19.6 14.5 8.9 9.1 2.7 12.3 7.7 14.0 55.4 12.7 158.0 33.0 22.7 3.9 16.8 58.0 26.2 129.9 15.7 4.5 23.3 23.7 15.9 19.7 14.0 15.0 16.4 23.0 9.5 5.2 17.2 16.1 113.0 14.1 11.0 20.3 5.4 8.9 16.0 20.5 10.5 14.5 48.4 10.4 6.5 21.7 91.8 26.8 10.7 6.3 4.3 12.8 9.3 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 10.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 19.2;Early spermatids: 20.8;Muller glia cells: 31.4;Rod photoreceptor cells: 22.2;Spermatocytes: 21.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.3;HMC-1: 3.4;JURKAT: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome NA NA "Vesicles, Aggresome" "HPA060238: AB_2684228" "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.4 0.0 0.0 0.0 0.7 0.0 0.0 1.2 9.3 0.9 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 2.7 2.2 1.8 0.0 0.0 0.5 1.5 0.5 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.0 0.0 1.2 1.9 15.4 1.2 0.0 0.0 0.0 19.2 7.9 0.0 11.6 7.6 20.8 0.2 0.0 0.0 1.1 0.2 0.5 5.4 0.0 0.0 0.9 11.1 0.0 1.8 0.0 2.5 0.6 0.0 5.0 4.6 0.0 31.4 7.2 0.0 0.7 0.0 22.2 0.0 1.2 21.5 3.2 3.8 0.0 0.0 0.0 0.1 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902647-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.5" "Lineage enriched" "Detected in many" 4 "monocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065352 Approved Vesicles,Aggresome NA NA Vesicles Aggresome "HPA065352: AB_2685477" "prognostic favorable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 3.3 10.8 6.5 1.5 3.2 1.7 2.1 1.0 6.6 3.1 5.6 2.8 4.0 4.2 1.6 6.2 3.2 1.7 4.7 7.5 4.8 4.0 8.6 20.9 5.0 2.4 2.7 2.9 2.9 8.2 0.5 6.0 2.9 3.7 2.7 3.0 4.5 4.8 1.5 6.6 1.2 4.3 2.2 1.6 2.2 3.5 4.7 3.5 0.1 4.6 2.1 1.4 1.6 1.5 0.1 2.6 0.0 10.5 0.0 0.8 1.1 4.3 5.2 0.4 2.0 2.7 8.1 3.0 6.7 4.4 5.3 2.8 4.7 3.1 7.2 10.6 7.1 1.3 1.7 1.7 1.2 0.6 2.3 13.6 4.3 3.9 7.9 1.2 9.6 6.3 4.7 3.9 1.9 0.7 3.3 2.0 1.3 1.2 1.6 3.2 6.5 0.5 8.5 4.4 4.4 7.7 1.0 2.8 2.8 8.3 6.3 16.0 12.0 8.3 1.5 2.4 2.1 3.7 3.6 4.5 6.4 7.3 8.9 3.9 3.3 2.4 1.7 4.2 2.9 6.5 0.0 3.6 0.0 0.4 10.5 0.0 0.0 0.2 0.8 2.6 0.1 0.4 0.4 0.0 0.0 5.1 0.7 0.1 1.1 6.5 3.2 1.0 6.6 4.8 4.0 2.7 2.9 3.7 3.5 8.9 8.8 1.4 3.8 2.3 1.9 10.2 28.1 10.7 9.1 21.0 0.0 16.4 16.6 8.2 12.9 1.1 7.3 0.0 12.1 8.3 6.7 6.1 1.1 53.9 8.1 3.2 7.5 2.5 4.0 1.0 13.0 3.7 8.5 1.8 11.1 4.7 9.5 11.5 9.9 19.5 3.8 0.0 1.9 6.1 2.3 2.5 9.8 0.7 15.3 4.3 CARD14 "BIMP2, CARMA2, PSORS2" ENSG00000141527 "Caspase recruitment domain family member 14" Q9BXL6 17 80169992-80209331 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.1;skin 1: 17.3;tongue: 12.3" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 4.0;Glandular cells: 4.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 7.3;SK-BR-3: 10.0;T-47d: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023388 Supported Aggresome,Cytosol NA NA Cytosol Aggresome "HPA023388: AB_1846020" "unprognostic (9.79e-3)" "unprognostic (3.86e-2)" "unprognostic (4.26e-1)" "unprognostic (1.05e-5)" "unprognostic (2.65e-2)" "unprognostic (1.37e-2)" "unprognostic (2.92e-4)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (2.63e-1)" "unprognostic (3.01e-1)" "unprognostic (5.48e-2)" "unprognostic (1.62e-8)" "unprognostic (2.52e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-1)" 0.4 1.9 0.4 0.9 0.4 0.1 3.2 0.4 0.7 4.0 0.4 0.4 0.4 2.1 0.8 1.0 12.1 0.3 0.6 0.4 0.4 0.3 0.7 1.1 0.7 1.0 0.4 0.4 1.0 0.4 0.0 0.4 3.0 0.6 2.1 0.0 0.4 6.2 3.6 0.6 17.3 1.6 0.4 1.5 1.8 0.5 0.8 0.4 0.4 0.4 12.3 10.7 1.3 5.8 2.0 0.0 0.0 0.5 0.0 0.4 0.1 3.9 0.6 0.6 0.2 0.0 0.0 3.9 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.8 0.0 2.0 0.2 0.0 0.3 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 1.3 0.0 7.3 0.0 0.0 0.1 2.6 0.5 0.0 1.6 0.4 0.0 3.1 0.5 0.1 0.0 10.0 1.6 0.6 22.0 0.0 0.2 0.1 0.5 0.4 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.3 2.0 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.4 0.4 0.7 0.4 0.3 0.4 0.4 0.6 0.4 0.0 1.4 0.0 3.4 1.5 0.8 0.8 2.5 4.0 1.2 0.0 0.0 0.2 0.0 0.6 0.6 0.5 0.0 0.0 2.0 0.3 0.5 4.0 0.0 0.0 0.7 0.0 0.0 0.6 3.2 0.0 0.3 0.7 1.7 0.0 0.0 2.2 1.3 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.4 2.6 1.3 0.0 0.1 3.3 CBLC "CBL-3, CBL-SL, RNF57" ENSG00000142273 "Cbl proto-oncogene C" Q9ULV8 19 44777869-44800634 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB008087, HPA035266" Approved Approved Nucleoplasm,Aggresome NA NA Nucleoplasm Aggresome "CAB008087: AB_2228531, HPA035266: AB_2674542" "unprognostic (1.58e-1)" "unprognostic (2.25e-1)" "unprognostic (8.21e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (3.91e-2)" "unprognostic (1.67e-1)" "unprognostic (2.13e-2)" "unprognostic (3.82e-1)" "unprognostic (7.39e-2)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.11e-6)" "unprognostic (3.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.90e-2)" "unprognostic (2.21e-3)" 0.1 0.0 0.5 8.5 0.2 0.0 4.8 0.1 0.4 4.4 39.5 0.1 3.2 29.5 1.7 1.7 22.0 1.4 18.8 0.1 0.6 0.0 4.9 15.1 1.3 0.1 0.1 0.3 0.8 18.1 0.9 0.7 4.1 0.2 6.9 6.9 0.5 11.4 5.2 0.1 20.8 66.8 0.4 0.1 0.1 10.2 1.6 0.1 0.5 1.9 13.2 15.7 7.6 8.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 19.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 12.9 26.3 0.0 0.0 0.0 0.0 18.4 0.0 16.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.9 0.0 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.0 14.6 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.0 0.1 0.3 0.2 0.1 0.0 1.6 0.0 28.6 13.4 0.0 0.2 5.1 5.3 11.4 7.0 0.0 4.6 1.7 37.5 0.0 0.1 105.9 0.0 42.7 1.3 0.4 14.4 0.0 8.5 0.3 0.0 16.7 0.0 0.0 0.0 0.0 0.9 0.0 1.0 35.8 0.0 67.6 84.2 0.0 9.9 0.0 0.0 0.4 0.0 1.7 22.5 2.1 0.7 54.6 56.4 CHCHD7 "COX23, MGC2217" ENSG00000170791 "Coiled-coil-helix-coiled-coil-helix domain containing 7" Q9BUK0 8 56211686-56218798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050783 Approved Approved "Cell Junctions,Aggresome" NA NA "Cell Junctions" Aggresome "HPA050783: AB_2681236" "unprognostic (1.64e-2)" "unprognostic (3.23e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.46e-2)" "unprognostic (2.43e-1)" "unprognostic (5.04e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "prognostic favorable (9.47e-5)" "unprognostic (1.94e-1)" "unprognostic (5.07e-1)" "unprognostic (1.77e-2)" "unprognostic (2.50e-1)" 16.6 14.8 24.1 19.6 29.4 17.6 18.9 27.1 23.3 17.6 20.7 18.3 22.8 22.5 13.1 34.3 15.7 17.6 12.3 27.0 21.0 19.5 23.4 18.0 19.4 24.4 27.0 16.0 36.3 20.0 22.5 48.3 13.3 26.7 19.2 21.3 19.2 34.5 18.0 23.2 14.6 26.2 14.8 32.0 33.0 17.7 7.6 24.8 27.4 19.8 18.3 24.9 15.5 16.4 31.0 33.6 26.2 20.6 24.2 31.1 17.3 18.7 6.0 13.5 4.4 35.9 25.5 13.9 13.4 12.7 10.7 8.0 15.4 23.0 17.8 11.9 7.9 14.8 10.6 13.9 20.7 13.3 7.7 26.8 27.1 14.3 21.2 18.2 23.1 17.4 30.4 19.1 7.6 34.1 15.2 11.1 33.4 13.2 11.7 25.3 9.4 23.1 34.3 11.8 30.0 8.7 26.5 4.1 14.8 19.8 20.3 3.5 2.3 7.0 11.0 9.9 16.9 11.5 13.0 16.1 5.7 12.1 18.3 12.6 12.3 12.6 29.6 15.9 34.4 9.7 21.5 20.6 26.2 23.2 19.0 22.5 31.0 26.0 23.6 22.8 26.4 31.1 27.8 7.9 24.2 16.6 33.6 29.7 17.3 24.1 29.4 27.1 23.3 21.0 19.5 27.0 16.0 26.7 24.8 17.9 68.8 75.2 36.1 18.4 31.3 84.5 48.4 44.2 40.9 47.1 13.7 38.6 106.1 35.3 16.9 29.6 88.5 23.3 65.0 72.3 25.3 33.7 52.0 63.7 129.2 12.7 38.1 46.6 72.1 9.6 34.2 55.9 50.6 69.5 53.7 38.5 58.7 54.7 29.0 49.6 34.8 12.9 36.3 52.6 37.9 20.8 35.2 57.5 63.2 39.1 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 11.8 3.7 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 7.3 10.7 33.3 2.2 35.3 6.6 2.8 20.5 3.9 1.5 2.2 3.6 29.9 5.4 23.4 6.2 10.0 0.4 4.0 5.6 8.1 11.5 2.8 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 56.6 96.8 35.0 6.3 18.3 4.1 2.8 17.8 6.7 20.5 15.7 9.8 8.0 0.0 6.0 9.1 11.3 14.8 0.0 10.5 26.0 8.7 10.9 23.1 65.7 15.8 1.6 8.1 14.7 33.3 37.6 7.8 35.8 15.1 47.7 22.7 3.5 14.0 0.0 8.5 7.0 3.5 0.0 12.2 6.7 2.0 23.8 34.2 21.4 10.1 16.1 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 30.1;U-266/70: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 55.9 0.7 2.3 0.0 6.8 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 6.0 30.7 12.5 0.5 2.5 0.0 1.6 2.5 2.7 10.3 1.8 0.0 0.4 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.5 1.4 0.3 12.7 0.9 58.9 0.0 0.0 4.3 187.9 0.4 0.3 86.1 1.7 7.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.2 0.5 1.0 0.8 45.8 0.0 0.9 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.5 0.6 4.9 0.1 0.2 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.0 0.9 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.2 3.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 6.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.3 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.9;Late spermatids: 59.0;Muller glia cells: 32.0;Sertoli cells: 51.8;Smooth muscle cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 20 "T-cells: 2.6" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEK 293: 6.7;SK-MEL-30: 6.1;TIME: 13.9;U-266/70: 16.9" "Region enriched" "Detected in all" 4 "olfactory region: 34.5" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.0 1.8 7.4 1.8 9.2 0.7 5.5 5.7 11.8 10.4 2.9 13.1 0.7 2.2 11.3 24.0 2.8 19.3 7.6 28.5 8.2 6.2 3.6 7.8 3.7 1.2 8.2 11.4 10.7 4.1 7.1 5.4 5.4 12.8 2.3 2.4 10.4 3.0 4.5 19.1 2.1 2.2 2.9 11.3 2.9 2.0 6.5 7.2 0.0 3.6 4.9 1.4 3.5 4.9 0.0 0.0 0.0 0.1 0.0 2.6 0.4 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.4 6.7 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.5 0.0 0.4 0.0 0.0 3.0 0.0 0.3 0.5 0.6 0.8 0.0 0.1 2.2 0.0 0.0 0.0 6.1 3.2 1.8 0.0 13.9 0.3 0.0 0.1 0.7 16.9 0.3 0.1 0.6 0.0 1.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 0.0 0.4 7.4 9.2 5.7 5.9 8.2 6.2 8.2 11.4 12.8 7.2 3.0 0.6 0.5 0.3 3.4 0.4 17.9 0.0 6.7 1.2 0.0 7.9 0.0 8.3 0.0 37.9 3.7 0.0 23.3 1.6 0.1 3.0 0.3 0.0 7.3 0.1 1.6 0.0 1.3 0.3 59.0 6.1 0.6 3.3 0.0 0.0 32.0 1.8 0.0 21.9 4.2 5.0 51.8 35.0 10.8 7.0 1.8 0.0 0.5 0.0 0.4 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 24.9;Late spermatids: 27.7;Proximal tubular cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 7.1" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "HEK 293: 17.5;U-266/84: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome NA NA Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 6.3 7.5 6.4 4.8 8.0 1.7 7.7 2.3 6.1 8.2 14.3 2.5 6.8 11.1 6.4 11.0 7.0 6.5 7.5 8.5 4.3 3.5 19.4 10.5 3.6 4.3 3.5 3.6 9.7 15.5 4.0 8.8 1.5 4.3 8.0 6.2 10.1 7.9 10.1 8.9 3.9 21.2 9.4 3.4 1.6 6.8 7.8 2.2 5.7 7.3 3.7 4.1 7.1 5.1 0.4 0.6 0.8 0.2 0.5 7.1 1.2 3.1 5.1 0.5 9.0 2.0 4.4 1.9 1.0 2.1 3.0 3.5 1.7 3.7 2.5 1.1 2.0 5.2 3.6 8.2 2.7 2.8 1.1 17.5 1.1 2.2 4.2 5.1 0.3 1.4 4.0 5.1 1.1 2.3 1.0 2.1 10.7 3.0 6.5 1.7 3.8 2.9 0.5 0.5 7.6 6.5 1.7 9.9 2.0 5.6 3.5 0.9 1.2 2.2 6.7 7.9 1.4 7.6 0.2 0.9 1.9 1.4 3.6 3.3 10.2 17.8 0.1 2.2 0.1 2.7 0.8 0.2 0.5 0.3 0.1 0.4 0.4 2.4 0.4 0.1 0.4 7.1 1.3 0.8 0.5 0.1 0.6 1.0 1.2 6.4 8.0 2.3 6.1 4.3 3.5 3.5 3.6 4.3 2.2 11.9 2.6 0.9 6.2 3.2 2.7 4.4 0.0 4.0 1.2 7.0 2.0 6.0 24.9 1.9 11.0 4.5 2.8 0.0 6.8 3.6 3.6 3.7 0.0 5.0 0.7 0.0 4.1 5.5 0.6 27.7 4.9 0.6 6.8 0.0 3.4 4.8 2.4 3.1 3.5 33.6 1.8 0.0 3.7 3.2 7.5 1.4 2.9 0.0 6.0 3.5 IRS2 ENSG00000185950 "Insulin receptor substrate 2" Q9Y4H2 13 109752698-109786568 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "hTERT-HME1: 18.2;LHCN-M2: 17.3;SH-SY5Y: 19.1;THP-1: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016944, HPA054664" Approved Supported Aggresome,Cytosol NA NA Cytosol Aggresome "CAB016944: , HPA054664: AB_2682563" "unprognostic (2.87e-3)" "unprognostic (5.73e-3)" "unprognostic (4.39e-2)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (5.49e-3)" "unprognostic (2.10e-1)" "unprognostic (9.28e-2)" "unprognostic (9.70e-2)" "unprognostic (2.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.09e-2)" "unprognostic (6.21e-3)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (3.17e-2)" "unprognostic (1.24e-1)" 38.9 24.3 27.6 10.9 25.2 70.1 33.5 19.6 30.6 13.5 10.9 13.0 6.7 8.7 14.4 12.2 7.1 7.7 8.4 13.5 23.6 14.6 7.7 24.6 11.6 5.3 24.2 22.1 27.1 7.9 6.1 23.0 13.6 19.5 20.0 7.5 9.3 11.5 12.2 20.9 15.3 9.7 9.7 25.1 9.0 8.3 6.3 21.3 2.0 10.7 4.7 5.3 8.4 17.8 0.5 0.1 6.9 1.4 0.2 0.5 0.2 2.6 3.0 2.0 0.0 16.7 3.3 1.1 2.9 3.5 1.8 1.5 0.3 3.3 0.0 1.8 2.0 2.6 1.2 1.0 2.6 2.2 1.0 13.8 1.3 4.3 0.0 17.0 4.8 1.6 7.0 14.1 0.5 18.2 11.7 0.6 0.2 0.8 0.0 17.3 1.3 0.0 14.1 2.1 1.5 0.6 5.9 1.8 1.2 5.0 0.7 2.9 19.1 1.5 0.0 11.8 1.7 0.4 28.8 0.0 3.7 0.0 0.2 3.9 0.0 1.4 0.9 2.8 4.7 6.4 2.7 1.4 1.9 0.2 0.3 0.3 0.1 0.4 0.1 0.1 0.5 0.5 0.4 6.9 0.2 0.4 0.1 0.5 0.2 27.6 25.2 19.6 30.6 23.6 14.6 24.2 22.1 19.5 21.3 29.8 35.6 13.7 47.7 101.2 24.8 56.1 71.4 20.1 43.3 29.6 108.0 17.8 5.0 31.2 32.2 11.3 53.1 23.3 2.7 8.4 42.1 75.9 24.3 103.6 21.1 23.8 117.6 11.6 115.0 5.0 34.5 51.6 123.2 5.4 28.3 37.5 20.9 45.6 19.1 3.3 28.3 25.8 34.0 18.6 8.8 110.3 25.6 24.9 31.0 20.7 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" NA NA 21000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favorable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 14.0 26.6 19.9 8.8 52.4 6.4 15.0 31.2 34.6 18.3 20.0 14.8 9.8 17.3 17.5 19.0 11.5 15.8 17.1 26.0 20.7 26.6 28.7 26.5 15.8 11.0 17.0 19.0 17.4 20.2 43.0 22.9 30.7 28.7 17.9 19.9 13.8 15.1 18.1 14.6 10.8 19.4 17.4 17.6 12.4 16.0 20.7 15.7 13.4 25.8 7.6 11.5 15.3 11.6 12.8 18.7 23.4 24.4 16.6 18.3 17.7 8.0 9.4 17.1 11.9 33.5 25.9 20.5 19.5 27.8 17.7 9.5 5.3 19.7 9.8 26.6 24.0 12.0 12.0 8.3 12.4 17.7 4.2 5.7 5.1 9.0 12.4 15.7 12.1 22.8 19.0 21.7 9.0 11.8 37.6 17.0 9.2 14.6 12.9 22.2 7.8 7.5 5.6 5.5 10.2 9.2 11.5 16.9 24.2 23.5 6.0 8.4 11.9 17.7 20.6 8.6 17.8 9.0 11.1 16.4 18.9 9.2 10.0 7.4 18.2 23.9 18.2 18.9 7.7 14.7 13.5 24.4 23.4 12.4 23.8 12.0 12.8 15.4 13.7 18.7 11.4 16.9 14.1 15.4 16.6 21.9 13.0 18.3 17.7 19.9 52.4 31.2 34.6 20.7 26.6 17.0 19.0 28.7 15.7 47.6 29.1 31.2 36.5 34.1 48.8 52.0 33.1 21.4 20.5 78.5 45.2 90.9 8.3 48.2 66.3 35.8 59.3 46.7 46.4 73.7 50.5 38.7 8.1 58.9 45.3 38.1 59.5 36.8 54.3 25.1 32.5 33.8 27.0 41.5 40.4 43.5 41.4 31.7 57.7 48.2 40.9 77.6 42.2 46.1 97.5 26.5 95.3 20.6 32.4 30.2 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 25.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 2.9 6.1 1.7 1.3 2.3 25.1 1.3 2.8 1.8 1.9 2.0 1.0 2.3 4.0 4.3 3.8 1.9 2.1 1.6 1.9 2.2 6.4 1.6 1.4 1.3 4.6 2.9 4.3 2.6 1.2 2.8 1.2 1.3 1.8 2.6 1.0 1.5 2.2 1.6 1.5 3.4 9.0 2.3 1.2 1.3 1.1 1.4 2.1 2.8 2.6 1.6 2.8 1.3 4.3 4.2 4.7 6.8 7.0 5.0 4.8 7.0 6.1 3.2 3.9 3.8 3.9 11.3 2.5 4.5 5.1 3.3 7.4 3.8 7.9 4.4 15.3 7.2 11.3 2.0 4.4 9.4 5.1 5.2 2.0 5.5 5.5 2.9 2.3 6.8 4.6 16.0 6.0 1.5 8.4 9.2 8.8 2.2 5.2 6.7 8.5 7.0 3.0 3.8 12.4 5.8 9.7 2.4 8.0 6.2 3.2 8.4 2.9 5.0 3.0 9.8 4.5 8.9 8.9 13.1 3.9 6.1 3.9 1.5 1.1 2.8 2.0 2.6 2.8 1.0 1.8 2.3 2.1 1.4 2.4 2.4 1.5 1.6 2.6 1.7 1.8 1.3 6.0 6.4 7.5 3.7 16.0 7.7 9.8 2.5 1.4 6.8 3.5 11.8 0.4 0.0 1.2 1.8 4.4 2.6 0.0 1.2 0.7 6.1 5.3 8.1 11.5 3.2 19.1 8.1 6.2 9.8 1.7 3.1 7.2 11.8 1.8 2.9 11.8 1.7 0.0 3.9 2.1 7.4 0.0 19.6 3.0 13.5 8.7 1.1 5.0 4.0 2.5 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 6.2 12.3 16.6 5.8 12.6 1.5 9.7 15.6 20.3 12.8 8.8 11.7 13.2 5.5 14.7 13.8 8.5 15.2 8.3 16.3 12.6 10.6 12.9 5.5 6.6 4.1 13.3 14.5 22.0 10.3 30.3 17.5 11.8 12.0 11.0 4.9 10.4 14.2 17.9 22.3 13.1 4.7 10.4 9.6 7.3 8.9 25.1 12.9 2.3 19.4 5.5 5.2 9.9 9.1 1.8 1.5 0.0 0.4 3.1 3.5 0.8 5.2 7.6 7.7 7.5 6.4 4.1 7.2 4.3 6.0 4.6 2.3 8.8 11.7 4.2 9.2 5.6 6.5 3.1 4.6 14.8 2.4 3.1 1.8 4.4 2.8 3.1 8.1 1.4 5.9 5.9 12.6 4.6 16.7 9.9 3.6 8.7 2.1 2.3 5.4 4.9 1.0 3.0 3.2 5.9 2.9 3.7 1.2 3.3 9.7 4.8 8.2 9.9 3.4 9.6 5.2 7.4 18.3 4.0 1.5 2.8 11.5 3.7 1.8 5.4 3.0 1.6 8.5 1.1 2.6 0.0 0.4 0.0 2.4 0.3 3.5 1.1 2.3 1.1 0.6 1.8 2.7 2.9 0.0 3.1 0.2 1.5 1.0 0.8 16.6 12.6 15.6 20.3 12.6 10.6 13.3 14.5 12.0 12.9 11.9 16.9 0.5 8.0 3.2 18.1 1.0 5.1 29.4 22.7 17.4 9.8 17.6 6.6 11.1 22.9 3.5 0.7 0.0 9.6 6.1 6.7 4.7 2.3 2.6 4.6 11.1 7.5 8.0 1.0 17.7 10.9 1.4 3.3 8.2 2.7 9.4 7.1 0.0 11.3 4.4 17.6 12.9 7.2 50.8 17.7 5.3 22.1 2.5 4.5 3.9 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20-related kinase adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 186.9;Proximal tubular cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 13.8 28.6 13.8 7.9 11.7 32.7 9.2 8.8 13.5 6.4 13.7 16.9 4.9 18.8 10.3 9.5 8.9 5.7 7.9 15.2 15.3 11.5 35.2 50.5 7.2 10.1 15.8 11.0 7.8 9.1 3.9 14.1 11.6 12.7 7.1 15.9 10.1 7.1 7.7 48.3 4.4 21.3 7.4 21.0 7.3 4.7 7.8 9.4 8.3 9.7 7.8 7.7 6.2 6.2 24.1 10.4 9.7 8.6 16.3 10.4 9.6 3.9 6.8 11.9 15.2 19.4 24.6 8.4 8.0 14.0 11.2 17.0 9.0 3.8 0.0 5.3 12.7 13.8 4.0 11.5 7.6 20.3 4.6 9.4 4.8 3.2 19.9 14.7 5.6 5.4 20.8 6.9 14.3 12.8 20.9 8.4 9.2 10.2 1.7 60.3 2.1 5.1 9.8 16.0 3.7 7.0 7.0 4.6 2.9 9.5 3.2 2.0 9.8 5.5 4.2 23.6 22.7 2.2 10.8 8.1 6.9 5.3 8.7 6.1 6.7 11.8 1.8 11.6 2.5 6.4 3.4 8.0 9.7 6.0 8.6 5.4 16.7 8.0 8.6 10.4 24.1 10.4 10.3 1.6 16.3 7.5 4.6 9.5 9.6 13.8 11.7 8.8 13.5 15.3 11.5 15.8 11.0 12.7 9.4 8.9 3.4 20.8 6.4 1.9 10.4 29.0 15.3 5.3 3.4 14.0 78.5 41.3 33.2 9.4 3.0 4.9 62.6 186.9 13.6 22.9 10.8 10.0 5.7 77.9 16.8 11.1 16.3 3.1 17.8 5.8 10.0 8.3 15.1 17.2 23.2 13.5 11.0 26.2 3.5 173.8 17.1 6.5 4.1 27.0 44.7 1.3 23.3 9.6 22.7 7.7